Promedior Inc., a biotechnology company relocating here from Greater Philadelphia, has opened new office and lab space in Lexington, the Massachusetts Life Sciences Center said Monday.
The company is looking to develop treatments for fibrosis, and it said it has raised a total of $65 million in funding to date.
A press release forwarded by the Massachusetts Life Sciences Center, the quasi-public agency charged with implementing Governor Deval Patrick’s life sciences initiative, included a statement from Suzanne L. Bruhn, president and chief executive of Promedior.
In a statement, Bruhn said: “We were attracted to the unique resources of the Massachusetts life sciences industry, which includes the full complement of world class companies involved in drug development along with highly innovative government initiatives that support biotechnology companies. Our new facility in Massachusetts positions us to expand our capabilities and accelerate our products forward, as we attract a highly-skilled team to develop and commercialize breakthrough therapeutics to treat fibrotic diseases for which there are few, if any, treatment options for patients.”
In a statement of his own, Lieutenant Governor Timothy Murray said, “Governor Patrick and I are excited to welcome Promedior to the vibrant Massachusetts biotechnology cluster.”